{
  "format": "listen-step-protocol@1",
  "kind": "module",
  "name": "IGROV-1 RPMI 1640 medium with 10% FBS",
  "tags": [
    "Cell culture",
    "Literature recipe"
  ],
  "steps": [],
  "labItems": [
    {
      "id": "component-igrov1-rpmi-medium",
      "kind": "recipe",
      "afterStep": 0,
      "snapshot": {
        "id": "literature-igrov1-rpmi-medium",
        "kind": "recipe",
        "name": "IGROV-1 RPMI 1640 medium with 10% FBS",
        "category": "Cell culture",
        "tags": [
          "Cell culture",
          "Literature recipe"
        ],
        "steps": [],
        "materials": [
          {
            "name": "RPMI 1640 medium",
            "detail": "Basal medium"
          },
          {
            "name": "FBS",
            "detail": "10% (vol/vol) final"
          }
        ],
        "tables": [
          {
            "id": "complete-medium",
            "name": "IGROV-1 complete medium, 100 mL",
            "header": [
              "Component",
              "Final concentration",
              "Amount for 100 mL"
            ],
            "rows": [
              [
                "RPMI 1640",
                "Basal medium",
                "90 mL"
              ],
              [
                "FBS",
                "10% (vol/vol)",
                "10 mL"
              ]
            ]
          }
        ],
        "tableChoices": {},
        "author": "Listen Step",
        "origin": {
          "type": "curated-literature",
          "url": "https://doi.org/10.1038/s41596-022-00755-x",
          "reviewedAt": "2026-11-09"
        },
        "source": {
          "citation": "Wang X et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nature Protocols 18, 265–291 (2023).",
          "doi": "10.1038/s41596-022-00755-x",
          "url": "https://doi.org/10.1038/s41596-022-00755-x",
          "locator": "Procedure, in-vitro delivery evaluation, pre-seeding step (Step 28 in the source workflow)"
        },
        "review": {
          "status": "source-values-checked",
          "reviewedAt": "2026-11-09",
          "scope": "Complete-medium formulation only. It does not establish that this medium is optimal for every IGROV-1 assay or replace the cell supplier's guidance."
        },
        "createdAt": 1794182400000,
        "updatedAt": 1794182400000
      }
    }
  ],
  "materials": [
    {
      "name": "RPMI 1640 medium",
      "detail": "Basal medium"
    },
    {
      "name": "FBS",
      "detail": "10% (vol/vol) final"
    }
  ],
  "source": {
    "citation": "Wang X et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nature Protocols 18, 265–291 (2023).",
    "doi": "10.1038/s41596-022-00755-x",
    "url": "https://doi.org/10.1038/s41596-022-00755-x",
    "locator": "Procedure, in-vitro delivery evaluation, pre-seeding step (Step 28 in the source workflow)"
  },
  "review": {
    "status": "source-values-checked",
    "reviewedAt": "2026-11-09"
  }
}
